Weekly paclitaxel followed by 24 hour infusion high-dose 5-fluorouracil and leucovorin (T-HDFL) chemotherapy for hormone-refractory prostate cancer (HRPC).

被引:0
|
作者
Lin, CC [1 ]
Hsu, CH [1 ]
Cheng, AL [1 ]
Guan, JY [1 ]
Huang, CY [1 ]
Chen, J [1 ]
Pu, YS [1 ]
机构
[1] Natl Taiwan Univ, Taipei 10764, Taiwan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4738
引用
收藏
页码:440S / 440S
页数:1
相关论文
共 50 条
  • [31] PHASE II STUDY OF CETUXIMAB PLUS WEEKLY CISPLATIN AND 24-HOUR INFUSION OF HIGH-DOSE 5-FLUOROURACIL AND LEUCOVORIN FOR THE FIRST-LINE TREATMENT OF ADVANCED GASTRIC CANCER
    Yeh, K. H.
    Hsu, C. H.
    Hsu, C.
    Huang, C. L.
    Lin, C. H.
    Shen, Y. C.
    Wu, S. L.
    Chiou, T. J.
    Chao, Y.
    Cheng, A. L.
    ANNALS OF ONCOLOGY, 2008, 19 : 174 - 174
  • [32] A phase II study of irinotecan alternated with a weekly schedule of high-dose leucovorin and 48-hour 5-fluorouracil infusion in patients with metastatic colorectal cancer
    Rosati, G
    Rossi, A
    Reggiardo, G
    Manzione, L
    ONCOLOGY, 2002, 62 (03) : 209 - 215
  • [33] Randomized, phase II study comparing cisplatin and high-dose 5-fluorouracil/leucovorin with paclitaxel and high-dose 5-fluorouracil/leucovorin in patients with advanced gastric cancer and adenocarcinomas of the gastroesophageal junction
    Tesselaar, M. E.
    Luelmo, S.
    Polee, M.
    van Bochove, A.
    Ouwerkerk, J.
    Pruijt, H.
    Sleeboom, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [34] A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer
    Chen, LT
    Liu, TW
    Wu, CW
    Chung, TR
    Shiah, HS
    Jan, CM
    Liu, JM
    Whang-Peng, J
    Chang, JY
    ONCOLOGY, 2002, 63 (03) : 239 - 247
  • [35] A PHASE-II STUDY OF WEEKLY 24-HOUR INFUSION WITH HIGH-DOSE FLUOROURACIL WITH LEUCOVORIN IN COLORECTAL-CARCINOMA
    ARDALAN, B
    CHUA, L
    TIAN, EM
    REDDY, R
    SRIDHAR, K
    BENEDETTO, P
    RICHMAN, S
    LEGASPI, A
    WALDMAN, S
    MORRELL, L
    FEUN, L
    SAVARAJ, N
    LIVINGSTONE, A
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (04) : 625 - 630
  • [36] Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion:: Results of a randomized trial in patients with advanced colorectal cancer
    Köhne, CH
    Schöffski, P
    Wilke, H
    Käufer, C
    Andreesen, R
    Ohl, U
    Klaasen, U
    Westerhausen, M
    Hiddemann, W
    Schott, G
    Harstick, A
    Bade, J
    Horster, A
    Schubert, U
    Hecker, H
    Dörken, B
    Schmoll, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) : 418 - 426
  • [37] Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract
    Hsu, C
    Shen, YC
    Yang, CH
    Yeh, KH
    Lu, YS
    Hsu, CH
    Liu, HT
    Li, CC
    Chen, JS
    Wu, CY
    Cheng, AL
    BRITISH JOURNAL OF CANCER, 2004, 90 (09) : 1715 - 1719
  • [38] Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract
    C Hsu
    Y-C Shen
    C-H Yang
    K-H Yeh
    Y-S Lu
    C-H Hsu
    H-T Liu
    C-C Li
    J-S Chen
    C-Y Wu
    A-L Cheng
    British Journal of Cancer, 2004, 90 : 1715 - 1719
  • [39] A phase II study of irinotecan alternated with a weekly schedule of oxaliplatin, high-dose leucovorin and 48-hour infusion 5-fluorouracil in patients with advanced colorectal cancer
    Rosati, G
    Tucci, A
    Rinaldi, A
    Colarusso, D
    Pizza, C
    Reggiardo, G
    Manzione, L
    ONCOLOGY, 2004, 66 (05) : 371 - 378
  • [40] Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen
    André, T
    Louvet, C
    Raymond, E
    Tournigand, C
    de Gramont, A
    ANNALS OF ONCOLOGY, 1998, 9 (11) : 1251 - 1253